Eris Lifesciences

• A clinical trial to study the effect of three drugs Sitagliptin Gliclazide and Metformin

  Status unknown, 24 people, 17 Aug 2026

Sources: trialsearch.who.int

• Targeted Assessment in High-Risk Patients With Diabetes to Identify Undiagnosed Heart Failure (TARTAN-HF)

  Fees or honoraria, 11 Aug 2026

• Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials

  Fees or honoraria, 20 Aug 2021

Sources: pubmed.ncbi.nlm.nih.gov